Heska (NASDAQ:HSKA) is set to release its earnings data before the market opens on Wednesday, February 28th. Analysts expect Heska to post earnings of $0.60 per share for the quarter.
Shares of Heska (HSKA) opened at $59.71 on Wednesday. Heska has a 1 year low of $56.59 and a 1 year high of $115.00. The stock has a market cap of $442.23, a PE ratio of 31.26, a P/E/G ratio of 1.58 and a beta of 0.67.
A number of brokerages have commented on HSKA. B. Riley reissued a “hold” rating and set a $96.50 price objective on shares of Heska in a report on Friday, October 27th. Raymond James Financial reissued a “buy” rating on shares of Heska in a report on Monday, December 4th. BidaskClub raised shares of Heska from a “sell” rating to a “hold” rating in a report on Thursday, December 21st. Aegis reissued a “buy” rating on shares of Heska in a report on Tuesday, December 19th. Finally, Zacks Investment Research lowered shares of Heska from a “hold” rating to a “sell” rating in a report on Wednesday, January 3rd. Three research analysts have rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $110.08.
In other Heska news, insider Michael J. Mcginley sold 7,826 shares of the stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $87.14, for a total transaction of $681,957.64. Following the sale, the insider now owns 106,771 shares of the company’s stock, valued at approximately $9,304,024.94. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 14.70% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: “Heska (HSKA) to Release Earnings on Wednesday” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/21/heska-hska-to-release-earnings-on-wednesday.html.
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.